September 2010 Br J Cardiol 2010;17:s3-s4
BJCardio staff
Abstract
A new and exciting ‘journey’ in interventional cardiology began more than 20 years ago with the introduction of intracoronary stenting. ...
|
View
September 2010 Br J Cardiol 2010;17:s5-s8
BJCardio staff
Abstract
Treatment options in ACS include optimised medical therapy, intervention and surgical revascularisation. ...
|
View
September 2010 Br J Cardiol 2010;17:s9-s14
BJCardio staff
Abstract
The first widely used antiplatelet agent, aspirin, continues to be standard therapy in ACS patients. The meta-analysis of the Antithrombotic Trialists’ Collaboration showed a 40% reduction in the rate of vascular events with aspirin.1...
|
View
